Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
MannKind Corp
MNKD
$1.32B
| $11.8M | 0.01% |
2,717,019
+226,234
| +9% | +$1.02M |
|
1827
CALL
Yum! Brands
YUM
$42.1B
| $11.8M | 0.01% |
96,600
| – | – |
|
1828
Walker & Dunlop
WD
$1.38B
| $11.8M | 0.01% |
104,064
+59,743
| +135% | +$6.26M |
|
|
HEPS
1829
D-Market Electronic Services & Trading
HEPS
$918M
| $11.8M | 0.01% |
+1,720,063
| New | +$18.7M |
|
1830
Nektar Therapeutics
NKTR
$2.52B
| $11.8M | 0.01% |
43,797
+5,371
| +14% | +$1.29M |
|
|
CTOS.WS
1831
CALL
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| $11.8M | 0.01% |
5,410,617
+1,158,071
| +27% | +$2.26M |
|
|
TBCP
1832
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
| $11.8M | 0.01% |
1,206,671
-266,615
| -18% | -$2.59M |
|
|
JNPR
1833
DELISTED
Juniper Networks
JNPR
| $11.8M | 0.01% |
427,518
-1,762,005
| -80% | -$49.6M |
|
1834
Domo
DOMO
$178M
| $11.8M | 0.01% |
139,311
+33,356
| +31% | +$2.86M |
|
|
NSTC
1835
DELISTED
Northern Star Investment Corp. III
NSTC
| $11.8M | 0.01% |
1,206,879
+751,514
| +165% | +$7.31M |
|
|
BSKYU
1836
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $11.7M | 0.01% |
1,175,962
-147,697
| -11% | -$1.47M |
|
|
OCA
1837
DELISTED
Omnichannel Acquisition Corp.
OCA
| $11.7M | 0.01% |
1,184,900
+227,094
| +24% | +$2.24M |
|
1838
ASE Group
ASX
$97B
| $11.7M | 0.01% |
1,493,688
+921,004
| +161% | +$8M |
|
|
SPAQ
1839
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $11.7M | 0.01% |
1,186,351
+467,411
| +65% | +$4.6M |
|
|
SGFY
1840
DELISTED
Signify Health, Inc.
SGFY
| $11.7M | 0.01% |
+655,026
| New | +$16.8M |
|
1841
AMC Entertainment Holdings
AMC
$2.33B
| $11.7M | 0.01% |
+30,744
| New | +$12.4M |
|
1842
PUT
Teva Pharmaceuticals
TEVA
$44.2B
| $11.7M | 0.01% |
1,200,000
+490,000
| +69% | +$4.59M |
|
|
FTCV
1843
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
| $11.7M | 0.01% |
1,153,767
+586,325
| +103% | +$6.19M |
|
1844
Puma Biotechnology
PBYI
$473M
| $11.7M | 0.01% |
1,666,785
+1,010,130
| +154% | +$7.56M |
|
1845
PUT
International Flavors & Fragrances
IFF
$22.2B
| $11.7M | 0.01% |
87,300
-33,300
| -28% | -$4.89M |
|
1846
Commault Systems
CVLT
$5.57B
| $11.7M | 0.01% |
154,806
+27,371
| +21% | +$2.12M |
|
1847
RLI Corp
RLI
$5.95B
| $11.7M | 0.01% |
232,422
+98,728
| +74% | +$5.25M |
|
1848
Goldman Sachs BDC
GSBD
$1.13B
| $11.6M | 0.01% |
632,173
+375,182
| +146% | +$7.18M |
|
1849
Sabesp
SBS
$17.1B
| $11.6M | 0.01% |
8,445,512
+4,558,804
| +117% | +$6.05M |
|
1850
Unifirst Corp
UNF
$5.21B
| $11.6M | 0.01% |
54,506
+653
| +1% | +$144K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.